SD-Ahrem2Sage |
thymus weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (1000 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84 days
| 10 |
1.45 |
mg/g |
0.16 |
0.51 |
post excision weight measurement |
|
0 |
105895 |
3021 |
SD-Ahrem2Sage |
spleen weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (22 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84 days
| 10 |
0.28 |
% |
0.02 |
0.05 |
post excision weight measurement |
|
0 |
105901 |
3021 |
SD-Ahrem2Sage |
both ovaries weight to body weight ratio |
vehicle control condition (5 ml/kg) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84 days
| 10 |
0.05 |
% |
0.01 |
0.02 |
post excision weight measurement |
|
0 |
105921 |
3021 |
SD-Ahrem2Sage |
liver weight as percentage of body weight |
vehicle control condition (5 ml/kg) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84 days
| 10 |
3.43 |
% |
0.3 |
0.95 |
post excision weight measurement |
0.0 |
0 |
105726 |
3021 |
SD-Ahrem2Sage |
liver weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
liver mass |
female |
84 days
| 5 |
4.11 |
g |
0.48 |
1.07 |
post excision weight measurement |
|
0 |
106445 |
3025 |
SD-Ahrem2Sage |
kidney weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
kidney mass |
female |
84 days
| 5 |
0.99 |
g |
0.09 |
0.2 |
post excision weight measurement |
|
0 |
106449 |
3025 |
SD-Ahrem2Sage |
pancreas weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pancreas mass |
female |
84 days
| 5 |
330.0 |
mg |
110.0 |
245.97 |
post excision weight measurement |
|
0 |
106457 |
3025 |
SD-Ahrem2Sage |
brain weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
brain mass |
male |
84 days
| 5 |
0.5 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
0 |
106467 |
3025 |
SD-Ahrem2Sage |
thymus weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thymus mass |
female |
84 days
| 5 |
0.17 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
0 |
106465 |
3025 |
SD-Ahrem2Sage |
both testes wet weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
testis mass |
male |
84 days
| 12 |
0.91 |
g |
0.03 |
0.1 |
post excision weight measurement |
|
0 |
106489 |
3025 |
SD-Ahrem2Sage |
thymus weight to body weight ratio |
vehicle control condition (5 ml/kg) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84 days
| 10 |
1.61 |
mg/g |
0.19 |
0.6 |
post excision weight measurement |
|
0 |
105885 |
3021 |
SD-Ahrem2Sage |
thymus weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (3 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84 days
| 10 |
1.6 |
mg/g |
0.29 |
0.92 |
post excision weight measurement |
|
0 |
105887 |
3021 |
SD-Ahrem2Sage |
brain weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (300 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84 days
| 10 |
0.75 |
% |
0.05 |
0.16 |
post excision weight measurement |
|
0 |
105917 |
3021 |
SD-Ahrem2Sage |
both ovaries weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (100 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84 days
| 10 |
0.04 |
% |
0.02 |
0.05 |
post excision weight measurement |
|
0 |
105927 |
3021 |
SD-Ahrem2Sage |
both ovaries weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (300 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84 days
| 10 |
0.06 |
% |
0.01 |
0.02 |
post excision weight measurement |
|
0 |
105929 |
3021 |
SD-Ahrem2Sage |
liver weight as percentage of body weight |
2,3,7,8-tetrachlorodibenzo-p-dioxin (300 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84 days
| 10 |
3.55 |
% |
0.18 |
0.56 |
post excision weight measurement |
0.0 |
0 |
105730 |
3021 |
SD-Ahrem2Sage |
liver weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
liver mass |
male |
84 days
| 5 |
4.47 |
g |
0.22 |
0.49 |
post excision weight measurement |
|
0 |
106443 |
3025 |
SD-Ahrem2Sage |
heart weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
heart mass |
male |
84 days
| 5 |
0.38 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
0 |
106451 |
3025 |
SD-Ahrem2Sage |
spleen weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
spleen mass |
female |
84 days
| 5 |
0.26 |
g |
0.01 |
0.02 |
post excision weight measurement |
|
0 |
106461 |
3025 |
SD-Ahrem2Sage |
thymus weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thymus mass |
male |
84 days
| 5 |
0.17 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
0 |
106463 |
3025 |
SD-Ahrem2Sage |
epididymides weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
epididymis mass |
male |
84 days
| 12 |
0.54 |
g |
0.06 |
0.21 |
post excision weight measurement |
|
0 |
106491 |
3025 |
SD-Ahrem2Sage |
liver weight as percentage of body weight |
2,3,7,8-tetrachlorodibenzo-p-dioxin (22 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84 days
| 10 |
3.43 |
% |
0.27 |
0.84 |
post excision weight measurement |
0.0 |
0 |
105728 |
3021 |
SD-Ahrem2Sage |
prostate gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
prostate mass |
male |
84 days
| 12 |
0.27 |
g |
0.04 |
0.14 |
post excision weight measurement |
|
0 |
106493 |
3025 |
SD-Ahrem2Sage |
thymus weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (100 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84 days
| 10 |
1.7 |
mg/g |
0.3 |
0.95 |
post excision weight measurement |
|
0 |
105891 |
3021 |
SD-Ahrem2Sage |
thymus weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (22 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84 days
| 10 |
1.6 |
mg/g |
0.23 |
0.73 |
post excision weight measurement |
|
0 |
105889 |
3021 |
SD-Ahrem2Sage |
spleen weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (100 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84 days
| 10 |
0.28 |
% |
0.02 |
0.07 |
post excision weight measurement |
|
0 |
105903 |
3021 |
SD-Ahrem2Sage |
both ovaries weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (22 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84 days
| 10 |
0.05 |
% |
0.01 |
0.03 |
post excision weight measurement |
|
0 |
105925 |
3021 |
SD-Ahrem2Sage |
heart weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
heart mass |
female |
84 days
| 5 |
0.41 |
g |
0.05 |
0.11 |
post excision weight measurement |
|
0 |
106453 |
3025 |
SD-Ahrem2Sage |
thyroid gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thyroid gland mass |
male |
84 days
| 5 |
0.01 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
0 |
106475 |
3025 |
SD-Ahrem2Sage |
both ovaries weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (3 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84 days
| 10 |
0.05 |
% |
0.01 |
0.03 |
post excision weight measurement |
|
0 |
105923 |
3021 |
SD-Ahrem2Sage |
brain weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (1000 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84 days
| 10 |
0.76 |
% |
0.05 |
0.16 |
post excision weight measurement |
|
0 |
105919 |
3021 |
SD-Ahrem2Sage |
liver weight as percentage of body weight |
2,3,7,8-tetrachlorodibenzo-p-dioxin (1000 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84 days
| 10 |
3.31 |
% |
0.21 |
0.67 |
post excision weight measurement |
0.0 |
0 |
105731 |
3021 |
SD-Ahrem2Sage |
spleen weight to body weight ratio |
vehicle control condition (5 ml/kg) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84 days
| 10 |
0.29 |
% |
0.02 |
0.07 |
post excision weight measurement |
|
0 |
105897 |
3021 |
SD-Ahrem2Sage |
brain weight to body weight ratio |
vehicle control condition (5 ml/kg) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84 days
| 10 |
0.74 |
% |
0.04 |
0.14 |
post excision weight measurement |
|
0 |
105909 |
3021 |
SD-Ahrem2Sage |
brain weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (22 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84 days
| 10 |
0.75 |
% |
0.05 |
0.16 |
post excision weight measurement |
|
0 |
105913 |
3021 |
SD-Ahrem2Sage |
liver weight as percentage of body weight |
2,3,7,8-tetrachlorodibenzo-p-dioxin (3 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84 days
| 10 |
3.35 |
% |
0.29 |
0.93 |
post excision weight measurement |
0.0 |
0 |
105727 |
3021 |
SD-Ahrem2Sage |
spleen weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
spleen mass |
male |
84 days
| 5 |
0.24 |
g |
0.02 |
0.04 |
post excision weight measurement |
|
0 |
106459 |
3025 |
SD-Ahrem2Sage |
thyroid gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
thyroid gland mass |
female |
84 days
| 5 |
0.01 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
0 |
106477 |
3025 |
SD-Ahrem2Sage |
pituitary gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pituitary gland mass |
male |
84 days
| 5 |
0.0 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
0 |
106483 |
3025 |
SD-Ahrem2Sage |
both ovaries weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
ovary mass |
female |
84 days
| 12 |
0.04 |
g |
0.0 |
0.01 |
post excision weight measurement |
|
0 |
106487 |
3025 |
SD-Ahrem2Sage |
both ovaries weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (1000 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
ovary mass |
female |
84 days
| 10 |
0.04 |
% |
0.01 |
0.03 |
post excision weight measurement |
|
0 |
105931 |
3021 |
SD-Ahrem2Sage |
pituitary gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pituitary gland mass |
female |
84 days
| 5 |
0.01 |
g |
0.0 |
0.0 |
post excision weight measurement |
|
0 |
106485 |
3025 |
SD-Ahrem2Sage |
thymus weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (300 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
thymus mass |
female |
84 days
| 10 |
1.61 |
mg/g |
0.2 |
0.63 |
post excision weight measurement |
|
0 |
105893 |
3021 |
SD-Ahrem2Sage |
spleen weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (300 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84 days
| 10 |
0.27 |
% |
0.01 |
0.04 |
post excision weight measurement |
|
0 |
105905 |
3021 |
SD-Ahrem2Sage |
brain weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (100 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84 days
| 10 |
0.73 |
% |
0.05 |
0.15 |
post excision weight measurement |
|
0 |
105915 |
3021 |
SD-Ahrem2Sage |
liver weight as percentage of body weight |
2,3,7,8-tetrachlorodibenzo-p-dioxin (100 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
liver mass |
female |
84 days
| 10 |
3.32 |
% |
0.28 |
0.87 |
post excision weight measurement |
0.0 |
0 |
105729 |
3021 |
SD-Ahrem2Sage |
kidney weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
kidney mass |
male |
84 days
| 5 |
0.94 |
g |
0.07 |
0.16 |
post excision weight measurement |
|
0 |
106447 |
3025 |
SD-Ahrem2Sage |
pancreas weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
pancreas mass |
male |
84 days
| 5 |
280.0 |
mg |
40.0 |
89.44 |
post excision weight measurement |
|
0 |
106455 |
3025 |
SD-Ahrem2Sage |
lung weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
lung mass |
male |
84 days
| 5 |
0.55 |
g |
0.05 |
0.11 |
post excision weight measurement |
|
0 |
106471 |
3025 |
SD-Ahrem2Sage |
adrenal gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
adrenal gland mass |
male |
84 days
| 5 |
21.0 |
mg |
17.0 |
38.01 |
post excision weight measurement |
|
0 |
106479 |
3025 |
SD-Ahrem2Sage |
spleen weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (3 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84 days
| 10 |
0.29 |
% |
0.04 |
0.12 |
post excision weight measurement |
|
0 |
105899 |
3021 |
SD-Ahrem2Sage |
spleen weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (1000 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
spleen mass |
female |
84 days
| 10 |
0.28 |
% |
0.03 |
0.08 |
post excision weight measurement |
|
0 |
105907 |
3021 |
SD-Ahrem2Sage |
brain weight to body weight ratio |
2,3,7,8-tetrachlorodibenzo-p-dioxin (3 ng/kg/d) (for 28 days) |
Harrill JA, et al., J Appl Toxicol. 2016 Jun;36(6):802-14. doi: 10.1002/jat.3211. Epub 2015 Aug 17. |
brain mass |
female |
84 days
| 10 |
0.76 |
% |
0.04 |
0.13 |
post excision weight measurement |
|
0 |
105911 |
3021 |
SD-Ahrem2Sage |
brain weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
brain mass |
female |
84 days
| 5 |
0.67 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
0 |
106469 |
3025 |
SD-Ahrem2Sage |
lung weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
lung mass |
female |
84 days
| 5 |
0.84 |
g |
0.35 |
0.78 |
post excision weight measurement |
|
0 |
106473 |
3025 |
SD-Ahrem2Sage |
adrenal gland weight |
control condition (for 84 days) |
Harrill JA, et al., Toxicol Appl Pharmacol. 2013 Oct 15;272(2):503-18. doi: 10.1016/j.taap.2013.06.024. Epub 2013 Jul 13. |
adrenal gland mass |
female |
84 days
| 5 |
25.0 |
mg |
2.0 |
4.47 |
post excision weight measurement |
|
0 |
106481 |
3025 |